Biotech

SAN FRANCISCO (AP) — A biotech executive, who was found guilty of insider trading by a jury, had allegedly made significant investments in a competitor’s stock. The verdict was announced following a trial that took place in San Francisco, California. This case highlighted the consequences of illicit financial activities among executives and the impact it can have on the integrity of the stock market. The unidentified executive was accused of using confidential information to trade shares of a rival company, resulting in unfair gains. The individual’s actions were uncovered during an investigation by the Securities … Read more